GDF5

protein-coding

growth differentiation factor 5, the group of Transforming growth factor beta superfamily|MicroRNA protein coding host genes

Gene summary

This gene encodes a secreted ligand of the TGF-beta (transforming growth factor-beta) superfamily of proteins. Ligands of this family bind various TGF-beta receptors leading to recruitment and activation of SMAD family transcription factors that regulate gene expression. The encoded preproprotein is proteolytically processed to generate each subunit of the disulfide-linked homodimer. This protein regulates the development of numerous tissue and cell types, including cartilage, joints, brown fat, teeth, and the growth of neuronal axons and dendrites. Mutations in this gene are associated with acromesomelic dysplasia, brachydactyly, chondrodysplasia, multiple synostoses syndrome, proximal symphalangism, and susceptibility to osteoarthritis. [provided by RefSeq, Aug 2016]

MANE transcript

NM_000557.5

Inheritance

AD, AR, SD

ClinVar variants

P:63U:212B:204

Top phenotype

Acromesomelic dysplasia 2C; Acromesomelic dysplasia 2B; Multiple synostoses syndrome 2; Acromesomelic dysplasia 2A; Symphalangism, proximal 1B; Brachydactyly, type A1, C; Brachydactyly, type A2; Brachydactyly, type C; Acromesomelic dysplasia 2C

gnomAD constraint

pLI —, LoF o/e 0.18

Max pathogenic AF

—

Genomic locus

chr20:35,433,347-35,454,746

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~21.4 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

brachydactyly type A1SUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0007215

Submitter: Orphanet

acromesomelic dysplasia 2BSUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0009231

Submitter: Orphanet

acromesomelic dysplasia 2ASTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0008703

Submitter: Labcorp Genetics (formerly Invitae)

brachydactyly type CSUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0007221

Submitter: Orphanet

acromesomelic dysplasia 2ASUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0008703

Submitter: Orphanet

acromesomelic dysplasia 2AMODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0008703

Submitter: Ambry Genetics

brachydactyly type A1CSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0014032

Submitter: Labcorp Genetics (formerly Invitae)

brachydactyly type A2SUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0007216

Submitter: Orphanet

acromesomelic dysplasia 2C, Hunter-Thompson typeSUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0008717

Submitter: Orphanet

multiple synostoses syndromeSUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0017923

Submitter: Orphanet

proximal symphalangismSUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0008511

Submitter: Orphanet

Angel-shaped phalango-epiphyseal dysplasiaSUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0007114

Submitter: Orphanet

acromelic dysplasiaSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0019695

Submitter: PanelApp Australia

brachydactylySTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0021004

Submitter: PanelApp Australia

symphalangism, proximal, 1BMODERATE

Inheritance Pattern: AD

Disease ID:MONDO:0014125

Submitter: Ambry Genetics

symphalangism, proximal, 1BSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0014125

Submitter: Labcorp Genetics (formerly Invitae)

acromesomelic dysplasia 2ADEFINITIVE

Inheritance Pattern: AR

Disease ID:MONDO:0008703

Submitter: G2P

brachydactyly type CDEFINITIVE

Inheritance Pattern: SD

Disease ID:MONDO:0007221

Submitter: Ambry Genetics

multiple synostoses syndrome 2STRONG

Inheritance Pattern: AD

Disease ID:MONDO:0012394

Submitter: PanelApp Australia

symphalangism, proximal, 1BDEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:0014125

Submitter: G2P

Clinical Genomic Database (CGD)

Acromesomelic dysplasia 2C; Acromesomelic dysplasia 2B; Multiple synostoses syndrome 2; Acromesomelic dysplasia 2A; Symphalangism, proximal 1B; Brachydactyly, type A1, C; Brachydactyly, type A2; Brachydactyly, type C; Acromesomelic dysplasia 2CAD/AR

Manifestation: Musculoskeletal

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 13953230; 14159881; 4850715; 964999; 2624264; 2703235; 2363425; 8954778; 8589725; 9288098; 9489798; 12357473; 12121354; 12567410; 14735582; 16127465; 16222676; 16532400; 16014698; 16957682; 16892395; 17384641; 18629880; 18283415; 19956691; 20683927Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to GDF5 variants in ClinVar

16 Conditions Cataloged
not providedTotal: 409
Inborn genetic diseasesTotal: 83
Grebe syndromeTotal: 38
Multiple synostoses syndrome 2Total: 30
Acromesomelic dysplasia 2BTotal: 30
GDF5-related disorderTotal: 29
Acromesomelic dysplasia 2C, Hunter-Thompson typeTotal: 28
Brachydactyly type CTotal: 20

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_000557.5. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
3
clinvar
192
clinvar
195
missense
10
clinvar
6
clinvar
204
clinvar
11
clinvar
1
clinvar
232
nonsense
10
clinvar
8
clinvar
2
clinvar
20
start loss
1
clinvar
1
frameshift
16
clinvar
13
clinvar
2
clinvar
31
splice donor/acceptor (+/-2bp)
0
Total36272122031479

Highest pathogenic variant AF is 0.000013141295

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 8 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_000557.5RefSeqNP_000548.22MANE Select
ENST00000374369.8EnsemblENSP00000363489.32MANE Select
NM_001319138.2RefSeqNP_001306067.12Standard
ENST00000374372.1EnsemblENSP00000363492.12Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • TGF-beta signaling pathway - Homo sapiens (human)
  • Hippo signaling pathway - Homo sapiens (human)
  • Cytokine-cytokine receptor interaction - Homo sapiens (human)
  • TGF-Core
  • Differentiation Pathway

Biological Process

  • chondrocyte differentiation
  • transforming growth factor beta receptor signaling pathway
  • cell-cell signaling
  • response to mechanical stimulus
  • regulation of signaling receptor activity

Molecular Function

  • cytokine activity
  • transforming growth factor beta receptor binding
  • protein binding
  • growth factor activity
  • BMP binding

Cellular Component

  • extracellular region
  • extracellular space
  • plasma membrane

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000374372
Coding exons
2
Length
21424
Individuals with no LoFs
125734
Homozygous LoFs
0
Heterozygous LoFs
7
Defined
125741
p
0.0000278
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense0.8942733180.8590.00002143199
Missense (PolyPhen)74117.010.632451223
Synonymous-1.211661471.130.00001031099
Loss of Function3.10316.70.1800.00000116158

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000130.00012rare
Latino/Admixed American0.0000290.000029rare
Ashkenazi Jewish0.000100.000099rare
East Asian00.0absent
Finnish00.0absent
European (Non-Finnish)0.0000190.000018rare
South Asian0.0000330.000033rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Growth factor involved in bone and cartilage formation. During cartilage development regulates differentiation of chondrogenic tissue through two pathways. Firstly, positively regulates differentiation of chondrogenic tissue through its binding of high affinity with BMPR1B and of less affinity with BMPR1A, leading to induction of SMAD1-SMAD5-SMAD8 complex phosphorylation and then SMAD protein signaling transduction (PubMed:24098149, PubMed:21976273, PubMed:15530414, PubMed:25092592). Secondly, negatively regulates chondrogenic differentiation through its interaction with NOG (PubMed:21976273). Required to prevent excessive muscle loss upon denervation. This function requires SMAD4 and is mediated by phosphorylated SMAD1/5/8 (By similarity). Binds bacterial lipopolysaccharide (LPS) and mediates LPS-induced inflammatory response, including TNF secretion by monocytes (PubMed:11276205). {ECO:0000250|UniProtKB:P43027, ECO:0000269|PubMed:11276205, ECO:0000269|PubMed:15530414, ECO:0000269|PubMed:19229295, ECO:0000269|PubMed:19956691, ECO:0000269|PubMed:21976273, ECO:0000269|PubMed:24098149, ECO:0000269|PubMed:25092592}.;
Disease
DISEASE: Acromesomelic chondrodysplasia, Hunter-Thompson type (AMDH) [MIM:201250]: An autosomal recessive form of dwarfism. Patients have limb abnormalities, with the middle and distal segments being most affected and the lower limbs more affected than the upper. AMDH is characterized by normal axial skeletons and missing or fused skeletal elements within the hands and feet. {ECO:0000269|PubMed:8589725}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Brachydactyly C (BDC) [MIM:113100]: A form of brachydactyly. Brachydactyly defines a group of inherited malformations characterized by shortening of the digits due to abnormal development of the phalanges and/or the metacarpals. Brachydactyly type C is characterized by deformity of the middle and proximal phalanges of the second and third fingers, sometimes with hypersegmentation of the proximal phalanx. The ring finger may be essentially normal and project beyond the others. {ECO:0000269|PubMed:14735582, ECO:0000269|PubMed:22828468, ECO:0000269|PubMed:25092592, ECO:0000269|PubMed:25820810}. Note=The disease is caused by mutations affecting the gene represented in this entry. Some BDC patients with GDF5 mutations also manifest clinical features of ASPED angel-shaped phalango- epiphyseal dysplasia (ASPED), an autosomal dominant skeletal abnormality characterized by a typical angel-shaped phalanx, brachydactyly, specific radiological findings, abnormal dentition, hip dysplasia, and delayed bone age. This suggests that BDC and ASPED are part of the same clinical spectrum (PubMed:22828468). {ECO:0000269|PubMed:22828468}.; DISEASE: Du Pan syndrome (DPS) [MIM:228900]: Rare autosomal recessive condition characterized by absence of the fibulae and severe acromesomelic limb shortening with small, non-functional toes. Although milder, the phenotype resembles the autosomal recessive Hunter-Thompson and Grebe types of acromesomelic chondrodysplasia. {ECO:0000269|PubMed:12121354, ECO:0000269|PubMed:16222676, ECO:0000269|PubMed:18629880}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Symphalangism, proximal 1B (SYM1B) [MIM:615298]: A disease characterized by the hereditary absence of the proximal interphalangeal joints. Distal interphalangeal joints are less frequently involved and metacarpophalangeal joints are rarely affected whereas carpal bone malformation and fusion are common. In the lower extremities, tarsal bone coalition is common. Conductive hearing loss is seen and is due to fusion of the stapes to the petrous part of the temporal bone. {ECO:0000269|PubMed:16127465, ECO:0000269|PubMed:16892395, ECO:0000269|PubMed:18283415}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Multiple synostoses syndrome 2 (SYNS2) [MIM:610017]: A bone disease characterized by multiple progressive joint fusions that commonly involve proximal interphalangeal, tarsal-carpal, humeroradial and cervical spine joints. Additional features can include progressive conductive deafness and facial dysmorphism. {ECO:0000269|PubMed:16532400, ECO:0000269|PubMed:19956691, ECO:0000269|PubMed:21976273, ECO:0000269|PubMed:24098149, ECO:0000269|Ref.18}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Brachydactyly A2 (BDA2) [MIM:112600]: A form of brachydactyly. Brachydactyly defines a group of inherited malformations characterized by shortening of the digits due to abnormal development of the phalanges and/or the metacarpals. In brachydactyly type A2 shortening of the middle phalanges is confined to the index finger and the second toe, all other digits being more or less normal. Because of a rhomboid or triangular shape of the affected middle phalanx, the end of the second finger usually deviates radially. {ECO:0000269|PubMed:16127465, ECO:0000269|PubMed:18203755, ECO:0000269|PubMed:21976273}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Osteoarthritis 5 (OS5) [MIM:612400]: A degenerative disease of the joints characterized by degradation of the hyaline articular cartilage and remodeling of the subchondral bone with sclerosis. Clinical symptoms include pain and joint stiffness often leading to significant disability and joint replacement. {ECO:0000269|PubMed:17384641}. Note=Disease susceptibility is associated with variations affecting the gene represented in this entry.; DISEASE: Brachydactyly A1, C (BDA1C) [MIM:615072]: A form of brachydactyly type A1. Brachydactyly defines a group of inherited malformations characterized by shortening of the digits due to abnormal development of the phalanges and/or the metacarpals. Brachydactyly type A1 is characterized by middle phalanges of all the digits rudimentary or fused with the terminal phalanges. The proximal phalanges of the thumbs and big toes are short. BDA1C inheritance can be autosomal dominant or autosomal recessive. Autosomal dominant BDA1C has a milder phenotype. {ECO:0000269|PubMed:20683927, ECO:0000269|PubMed:24098149}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.328

Intolerance Scores

LoFtool
0.158
RVIS EVS
-0.07
RVIS percentile EVS
48.69

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.965

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.